FLT4 Polyclonal Antibody

Verified Samples in IHC:Human lung cancer

IHC 1:30-1:150

Polyclonal

IgG

Synthetic peptide of human FLT4

FLT4

EC 2.7.10.1;flt 4;FLT-4;FLT4;FLT41;Fms related tyrosine kinase 4;Fms-like tyrosine kinase 4;LMPH1A;PCL;Soluble VEGFR3 variant 1;Soluble VEGFR3 variant 2;Soluble VEGFR3 variant 3;Tyrosine protein kinase receptor FLT4;Tyrosine-protein kinase receptor FLT4;Vascular endothelial growth factor receptor 3;Vascular endothelial growth factor receptor 3 precursor;VEGF R3;VEGFR 3;VEGFR-3;VEGFR3;VGFR3抗体

Membrane.

0.8 mg/mL

Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

PBS with 0.05% NaN3 and 40% Glycerol,pH7.4

Antigen affinity purification

Cancer; Cardiovascular; Epigenetics and Nuclear Signaling; Signal Transduction

Unconjugated

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting.